A carregar...

Bendamustine in the treatment of B-cell non-Hodgkin lymphoma

Bendamustine is a uniquely structuredalkylating agent that lacks cross-resistance with other alkylators. This agent has a high degreeof activity against a variety of tumor cell lines.Based on clinical data from randomized phase III trials, bendamustine, with or without rituximab, hasbeen shown to be...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: L G Babicheva, I V Poddubnaya
Formato: Artigo
Idioma:Russo
Publicado em: IP Habib O.N. 2018-12-01
Colecção:Современная онкология
Assuntos:
Acesso em linha:https://modernonco.orscience.ru/1815-1434/article/viewFile/29575/pdf
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!